Martin Shkreli: Big Pharma's Blind Spot, Betting Against Quantum & What Prison Taught Him
Martin Shkreli discusses his thesis that quantum computing is largely a fraud with limited practical business applications, reflects on lessons learned during his seven-year prison sentence, and shares his investment perspectives on AI, photonic computing, and pharmaceutical entrepreneurship.
Summary
Martin Shkreli opens by discussing quantum computing with significant skepticism, arguing that despite being presented as revolutionary, quantum computers have extremely limited practical business applications. He explains that quantum computers only excel at specific algorithms like integer factorization and discrete logarithm problems, running at hundreds to thousands of hertz rather than gigahertz speeds, making them inferior for most computational tasks including simple sorting algorithms. He notes that companies like OpenAI, Google, and IBM have shown little genuine business interest despite massive investment, and that he and his wife have tried every quantum computer in the world without being able to multiply 300 by 200. He has been short quantum computing companies but acknowledges losing millions on the timing.
Regarding future computing, Shkreli expresses interest in photonic computing as a potential paradigm shift, citing Microsoft research on optical computing and mentioning startups like Neuro Foss and OptiCore that are developing photonic matrix multiplication cores potentially superior to NVIDIA's offerings.
Shkreli then recounts his career trajectory, beginning at age 16 working for Jim Cramer's hedge fund, which focused on high-frequency trading. He transitioned to discovering that pharmaceutical molecule acquisition represented significant alpha opportunity, as large pharmaceutical companies like Pfizer and Bristol Myers would sell drug rights at undervalued prices. He describes buying drugs for millions that were worth billions, and later repositioning existing drugs for different disease indications—specifically mentioning sparsantan, which he repositioned from hypertension to FSGS (focal segmental glomerulosclerosis), becoming FDA-approved for a patient population that previously had no treatment options.
On artificial intelligence, Shkreli is bullish on the technology's long-term impact but skeptical of fear-mongering from effective altruism figures like Dario Amodei. He dismisses claims that AI will cure all diseases within a decade or cause mass unemployment, arguing that drug discovery remains fundamentally difficult despite computational advances. He believes the AI opportunity is boundless in terms of productive applications, mentioning Cohere's startup focused on reasoning models, and sees infinite demand for intelligence across sectors. He views Meta as potentially the biggest winner due to their distribution advantages with Llama, strong product capabilities, and their willingness to challenge AI safety narratives alongside figures like Elon Musk, the President, and Jensen Huang.
Shkreli is critical of effective altruism's approach, distinguishing it from effective accelerationism (eA) which he helped popularize. He views EA fear-mongering as narcissistic self-importance that misrepresents computational advances as existential threats.
On Sam Bankman-Fried, Shkreli describes him as a brilliant but unconventional thinker whose early investment portfolio in AI looked prescient in hindsight. He analogizes SBF's trajectory to Elizabeth Holmes and Roger Jotnam, suggesting that intellectually gifted individuals sometimes struggle with the psychological burden of maintaining a self-image of genius, leading to ethically compromised decisions when they underperform their own expectations.
Reflecting on his seven years in prison, Shkreli describes a transformative experience that taught him fundamental human commonalities—everyone has longing, friendship regrets, and shared vulnerabilities regardless of background. He identifies that his own downfall stemmed from an obsessive attachment to being perceived as a great trader, a fixation he now views as misguided when alternative paths to excellence existed. He credits prison with helping him recognize that many brilliant people excel in multiple domains but can be damaged by over-indexing on a single identity.
About this episode
<p dir="ltr">(0:00) Martin Shkreli joins the Besties!</p> <p dir="ltr">(0:55) Why quantum computing is a one-trick business and why he's betting against it</p> <p dir="ltr">(7:42) The drugs big pharma sells too cheap and his journey from hedge fund trader to pharma</p> <p dir="ltr">(11:37) AI, drug discovery, and who actually wins</p> <p dir="ltr">(21:32) Brilliance and rule-breaking, the gifted-kid trap & what prison taught him</p> <p><strong> </strong></p> <p dir="ltr">Thanks to our partners for making this possible!</p> <p><strong> </strong></p> <p dir="ltr">IREN is a vertically integrated AI Cloud platform, delivering data centers, compute and software for AI training and inference. <a href="https://iren.com/">https://iren.com/</a></p> <p><strong> </strong></p> <p dir="ltr">Oracle connects the data, applications, and infrastructure that turn AI into business outcomes—with the flexibility, choice, and control to optimize as AI evolves. http://oracle.com/ai</p> <p dir="ltr">EY helps tech innovators scale from startup to exit to megacap. You build the future. We'll handle the rest. <a href="http://www.ey.com">http://www.ey.com</a></p> <p><strong> </strong></p> <p dir="ltr">Meta believes the future is for everyone. We're focused on giving every person the tools to reach their full potential and making sure the benefits of technology are distributed to all. <a href="http://www.meta.com">http://www.meta.com</a></p> <p><strong> </strong></p> <p dir="ltr">Keel Infrastructure owns the power, land, and connectivity that HPC and AI run on - backed by secured energy assets and established grid interconnections across North America. <a href="https://keelinfra.com/">https://keelinfra.com/</a></p> <p><strong> </strong></p> <p dir="ltr">Airwallex - Agentic Global Business Accounts. Open local accounts in 70+ countries to accept payments, earn yield, pay globally, and manage spend. <a href="http://airwallex.com">http://airwallex.com</a></p> <p><strong> </strong></p> <p dir="ltr">PayPal has been revolutionizing commerce globally for more than 25 years. Creating innovative experiences that make moving money, selling, and shopping simple, personalized, and secure, PayPal empowers consumers and businesses in approximately 200 markets to join and thrive in the global economy. For more information, visit <a href="https://www.paypal.com">https://www.paypal.com</a></p> <p><strong> </strong></p> <p dir="ltr">Google for Startups connects founders with the right people, products, and best practices to help startups build faster and go further. <a href="https://startup.google.com/">https://startup.google.com/</a></p> <p><strong> </strong></p> <p dir="ltr">Explore ideas, industries, and technologies worth understanding with Chamath every week on Learn with Me: <a href="https://research.socialcapital.com/allin">https://research.socialcapital.com/allin</a></p> <p><strong> </strong></p> <p dir="ltr">Follow the besties: </p> <p dir="ltr">https://x.com/chamath</p> <p dir="ltr">https://x.com/Jason</p> <p dir="ltr">https://x.com/DavidSacks</p> <p dir="ltr">https://x.com/friedberg</p> <p><strong> </strong></p> <p dir="ltr">Follow on X:</p> <p dir="ltr">https://x.com/theallinpod</p> <p><strong> </strong></p> <p dir="ltr">Follow on Instagram:</p> <p dir="ltr">https://www.instagram.com/theallinpod</p> <p><strong> </strong></p> <p dir="ltr">Follow on TikTok:</p> <p dir="ltr">https://www.tiktok.com/@allin</p> <p><strong> </strong></p> <p dir="ltr">Follow on LinkedIn: </p> <p dir="ltr">https://www.linkedin.com/company/allinpod</p> <p><strong> </strong></p> <p dir="ltr">Intro Music Credit:</p> <p dir="ltr">https://rb.gy/tppkzl</p> <p dir="ltr">https://x.com/yung_spielburg</p> <p><strong> </strong></p> <p dir="ltr">#allin #tech #news</p>
Key Insights
- Shkreli argues that quantum computers are primarily valuable only for specific exponential-time algorithms like integer factorization, but because there are no business cases that require this specific computation at scale, quantum computing has minimal practical business application despite hundreds of millions in annual corporate investment.
- Shkreli contends that the pharmaceutical drug acquisition market was highly inefficient with major companies like Pfizer and Bristol Myers willing to sell drug rights for millions despite billion-dollar valuations, representing a structural market arbitrage opportunity he exploited through business development and clinical assessment.
- Shkreli claims that Sam Bankman-Fried, Elizabeth Holmes, and other brilliant individuals with failed trajectories share a common pattern: their exceptional intellect creates psychological pressure to maintain a fixed identity, and when that identity is threatened by underperformance, they become vulnerable to ethical compromise.
- Shkreli asserts that AI will not significantly accelerate drug discovery within a decade because the fundamental difficulty of drug development has not changed substantially despite computational advances, contradicting Anthropic executives' claims about AI-enabled pharmaceutical breakthroughs.
- Shkreli believes his seven-year imprisonment taught him that psychological patterns transcend socioeconomic status and background, with universal human vulnerabilities around friendship, recognition, and self-worth, while his specific failure stemmed from refusing to acknowledge that his true talent lay in entrepreneurship rather than trading.
Topics
Transcript
He's been called the most hated man in America because he jacked up the cost of a life-saving drug. Raised the price of a life-saving drug 5,000%. He became the poster child for capitalistic greed. Martin Shkreli, seven years in prison. We definitely plan on raising the price, that's for sure. You can be prosecuted for not maximizing profit, and you have to do everything in your power to make as much money as possible. And if I'm the enemy for you, good, I'm happy, man. I'm fulfilling some need in your life. Purchase the only copy of a legendary Wu-Tang Clan album with no immediate plans to play it. It's not a good record. Ego is the fountainhead of…
Full transcript available for MurmurCast members
Sign Up to AccessMore from All-In with Chamath, Jason, Sacks & Friedberg
Is Claude Conscious? Pope Rejects, Model Welfare Movement, OpenAI's Math Backlash, France Riots
The All In podcast discusses Anthropic's controversial efforts to obtain religious leaders' blessing for AI consciousness, OpenAI's major mathematical breakthroughs and their implications, and France's austerity-driven riots as a harbinger of broader Western economic crises driven by unsustainable socialism.
Trump's Super Intelligence Summit, AI Safety Accord, GDP Beats, Midterm Predictions
The All-In podcast discusses President Trump's White House AI Safety Summit where major tech CEOs agreed to the AI Safety Accord featuring internal controls, external audits, and board oversight. The hosts analyze the accord's significance for US competitiveness, debate economic data showing strong GDP and employment growth amid persistent inflation concerns, and discuss upcoming midterm election predictions while criticizing media coverage of a foiled plane hijacking.
Jake Paul & The Chainsmokers: Turning Fame into Funds, Jake Enters Politics? & Venture Bubble Signs
Jake Paul discusses his evolution from social media creator to entrepreneur and investor, while The Chainsmokers share their transition from music producers to venture capitalists. Both emphasize the importance of authentic audience building, translating attention into sustainable business, and the hard work required to succeed across multiple domains.
Daniel Ek: Life After Spotify, Broken Healthcare Incentives, Catching Disease Early & AI's Potential
Daniel Ek, Spotify's co-founder and now executive chairman, discusses his journey building Spotify and his new healthcare startup Neko, which aims to revolutionize preventative healthcare through comprehensive annual health scans combining blood work, dermatology imaging, and AI analysis at a $499 price point.
Anthropic IPO at Risk, Meta's Muse Pop, Token Prices Fall, Open Source Gains Share, Alignment Fails
The All-In podcast discusses the explosive proliferation of open-source AI models that are commoditizing frontier intelligence, the schizophrenic behavior of Anthropic leadership undermining its own IPO, and the emerging success of consumer-facing AI agents like Meta's Muse that could democratize AI benefits across society.